Drug intelligence / Profile preview

Bai Nian Dan

Development stage: Unknown
Lead developer: Universe Pharmaceuticals
Administration: Oral

Overview

Bai Nian Dan is a signature traditional Chinese medicine derivative (TCMD) product developed and marketed by Universe Pharmaceuticals. It is primarily indicated for physical wellness and the management of age-related conditions. The product is manufactured by the company's subsidiary, Jiangxi Universe, at its facilities in Ji'an, Jiangxi, China. Universe Pharmaceuticals has invested significantly in the brand's promotion through large-scale television advertising campaigns and strategic research and development collaborations, including a partnership with Japan-based Kitanihon Pharmaceutical. As a TCMD, Bai Nian Dan represents a modernized formulation of traditional Chinese herbal ingredients designed for systemic health maintenance in aging populations.

Brand names: Bai Nian Dan

Beyond the preview

Go deeper on Bai Nian Dan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bai Nian Dan.

Explore the full profile